surmount-1 trial tirzepatide non-diabetic obesity weight loss vs semaglutide: A new battle in treatment SURMOUNT-1: Adults achieve weight loss

Yoshimi R, Ueda A, Ozato K, Ishigatsubo Y

CareFirst Specialty Pharmacy Known For: Specialty-focused compounding pharmacy with dedicated sterile compounding division for peptides and injectables Key Strengths: Dedicated sterile compounding division with separate cleanroom environments Emerging semaglutide program with initial focus on quality and safety over volume Strong relationships with endocrinology and bariatric medicine practices Patient counseling services included with every GLP-1 prescription Notable: CareFirst's specialty pharmacy background means they bring hospital-grade sterile compounding standards to their GLP-1 products

What drives your monthly total Three levers move the number: which product you take (semaglutide versus tirzepatide versus another), your subscription tier, and brand-versus-compounded dispensing

2026 FDA Status GLP-1 patches are not FDA-approved for weight loss or any medical condition